Dehydroepiandrosterone and Cardiovascular Disease

Vitamins and Hormones
P MannellaA R Genazzani

Abstract

The dehydroepiandrosterone and its metabolite, dehydroepiandrosterone sulfate, have been for a long while at the center of interest for endocrinologists and cardiologists. Consolidated data show that the dehydroepiandrosterone and the dehydroepiandrosterone sulfate present protective actions on the cardiovascular system. These actions are accomplished directly through target tissues such as endothelial cells, smooth muscle cells, and cardiomyocytes. At this level, they are able to activate a complex group of receptor, not completely identified, which modulate important functions such as vasodilation, antiinflammation, and antithrombosis. These data support the hypothesis that dehydroepiandrosterone could be used as drug for primary prevention of cardiovascular disease especially during aging and potentially also in addition of the common therapeutic strategy for the treatment and prevention of cardiovascular disease recurrence. In this publication, the effects of dehydroepiandrosterone and dehydroepiandrosterone sulfate on the cardiovascular system have been elucidated, starting with an analysis of the molecular action at target organ levels. In the second part, we evaluated the clinical effects of this administration, consider...Continue Reading

Citations

Dec 7, 2018·Cardiovascular Toxicology·Habib HaybarNajmaldin Saki
Mar 21, 2020·Frontiers in Endocrinology·Benjamin Campbell
Mar 7, 2021·Mayo Clinic Proceedings·Mark W PatakyK Sreekumaran Nair
Nov 12, 2021·Bioscience Trends·Siwei ZhangLing Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Related Papers

Annals of the New York Academy of Sciences
A Vermeulen
Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Luciano Onder, Gian Luigi Nicolosi
Nihon rinsho. Japanese journal of clinical medicine
M Suzuki
© 2022 Meta ULC. All rights reserved